Lario Therapeutics
PrivateLast Round
Grant
Feb 19, 2026
Total Funding Raised
$8.4M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Lario Therapeutics is a biopharmaceutical company that develops first-in-class precision medicines for severe neurological disorders, including epileptic conditions and Parkinson's disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lario Therapeutics Comparables
Compare Lario Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Autifony Therapeutics Limited | 77% | |
| H. Lundbeck A/S | 72% | |
| Muna Therapeutics | 72% | |
Lario Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 19, 2026 | ||||
| Grant | Jul 22, 2024 |
Lario Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Epidarex Capital | Seed |
| AXXAM Family Office | Seed |
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
| Wellcome Trust | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 19, 2026
Received $2M from The Michael J. Fox Foundation and Wellcome Trust.
- Jan 21, 2026
Monthly visitors increased 113% MoM.
Lario Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Lario Therapeutics's valuation, stock price, and market status.